On December 13, 2022, Evidence Prime development lab in Poland became a partner of Klaster LifeScience Kraków, a Polish National Key Cluster focusing on Research and Development collaboration in Life Sciences.
"Evidence Prime is delighted to announce that we became a part of a LifeScience Kraków network," said Paweł Kunstman, Evidence Prime's president. "Becoming a part of this research-driven collaborative network enables Evidence Prime with wider R&D cooperation opportunities, better access to research grants, and allows a wider promotion of our activities on behalf of the whole Evidence-Based Healthcare community."
Klaster LifeScience Krakow is the collaborative network of businesses and institutions from the Southern Poland Region, which agreed to collaborate to develop and deliver to the market innovations in the field of life sciences. These organizations represent six areas of interest, i.e., biotechnology and life science business (BioF), research & development (R&D), science and education (Edu), healthcare (Med), business support (Biz), and local government (Gov) actively guiding and facilitating the cooperation at the regional level.
Evidence Prime has joined the cluster in the BioF area and supports the cluster's mission by creating innovative solutions and technologies to improve health services.
Before joining the Klaster, we have participated in the LifeScience Open Space 2022 #LSOS2022 - The open innovation forum - "Health tech - integrate to accelerate."
Pawel Kunstman has presented LaserAI and how living reviews, accelerated by Artificial Intelligence can support the fight against cancer. You can watch his presentation here:
Read more about how Evidence Prime supports the mission of Klaster LifeScience Krakow in our press release:
